Ilaria Attili

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Computed Tomography

Top Venues

Current oncology (Toronto, Ont.)

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ilaria Attili, Valeria Fuorivia, Gianluca Spitaleri, Carla Corvaja, Pamela Trillo Aliaga, Ester Del Signore, Riccardo Asnaghi, Ambra Carnevale Schianca, Antonio Passaro, Filippo de Marinis
Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials. Cancers 16 (13) (2024)
Federico Pio Fabrizio, Ilaria Attili, Filippo de Marinis
Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art. Cancers 16 (7) (2024)
Federico Pio Fabrizio, Ilaria Attili, Filippo de Marinis
Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art. Cancers 16 (7) (2024)
Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, Ester Del Signore, Carla Corvaja, Gloria Pellizzari, Jalissa Katrini, Antonio Passaro, Filippo de Marinis
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs". Cancers 16 (16) (2024)
Ilaria Attili, Riccardo Asnaghi, Davide Vacirca, Riccardo Adorisio, Alessandra Rappa, Alberto Ranghiero, Mariano Lombardi, Carla Corvaja, Valeria Fuorivia, Ambra Carnevale Schianca, Pamela Trillo Aliaga, Gianluca Spitaleri, Ester Del Signore, Juliana Guarize, Lorenzo Spaggiari, Elena Guerini-Rocco, Nicola Fusco, Filippo de Marinis, Antonio Passaro
Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis. Journal of clinical medicine 13 (15) (2024)
Ilaria Attili, Carla Corvaja, Gianluca Spitaleri, Pamela Trillo Aliaga, Ester Del Signore, Antonio Passaro, Filippo de Marinis
Post-Progression Analysis of EGFR -Mutant NSCLC Following Osimertinib Therapy in Real-World Settings. Cancers 16 (14) (2024)
Pamela Trillo Aliaga, Ester Del Signore, Valeria Fuorivia, Gianluca Spitaleri, Riccardo Asnaghi, Ilaria Attili, Carla Corvaja, Ambra Carnevale Schianca, Antonio Passaro, Filippo de Marinis
The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics. Genes 15 (6) (2024)
Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, Ester Del Signore, Carla Corvaja, Gloria Pellizzari, Jalissa Katrini, Antonio Passaro, Filippo de Marinis
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs". Cancers 16 (16) (2024)
Federico Pio Fabrizio, Ilaria Attili, Filippo de Marinis
Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art. Cancers 16 (7) (2024)
Ilaria Attili, Riccardo Asnaghi, Davide Vacirca, Riccardo Adorisio, Alessandra Rappa, Alberto Ranghiero, Mariano Lombardi, Carla Corvaja, Valeria Fuorivia, Ambra Carnevale Schianca, Pamela Trillo Aliaga, Gianluca Spitaleri, Ester Del Signore, Juliana Guarize, Lorenzo Spaggiari, Elena Guerini-Rocco, Nicola Fusco, Filippo de Marinis, Antonio Passaro
Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis. Journal of clinical medicine 13 (15) (2024)
Ilaria Attili, Carla Corvaja, Gianluca Spitaleri, Pamela Trillo Aliaga, Ester Del Signore, Antonio Passaro, Filippo de Marinis
Post-Progression Analysis of EGFR -Mutant NSCLC Following Osimertinib Therapy in Real-World Settings. Cancers 16 (14) (2024)
Ilaria Attili, Valeria Fuorivia, Gianluca Spitaleri, Carla Corvaja, Pamela Trillo Aliaga, Ester Del Signore, Riccardo Asnaghi, Ambra Carnevale Schianca, Antonio Passaro, Filippo de Marinis
Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials. Cancers 16 (13) (2024)
Ilaria Attili, Carla Corvaja, Gianluca Spitaleri, Pamela Trillo Aliaga, Ester Del Signore, Antonio Passaro, Filippo de Marinis
Post-Progression Analysis of EGFR -Mutant NSCLC Following Osimertinib Therapy in Real-World Settings. Cancers 16 (14) (2024)
Pamela Trillo Aliaga, Ester Del Signore, Valeria Fuorivia, Gianluca Spitaleri, Riccardo Asnaghi, Ilaria Attili, Carla Corvaja, Ambra Carnevale Schianca, Antonio Passaro, Filippo de Marinis
The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics. Genes 15 (6) (2024)
Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, Ester Del Signore, Carla Corvaja, Chiara Corti, Jacopo Uliano, Antonio Passaro, Filippo de Marinis
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target. Cancers 15 (19) (2023)
Francesco Petrella, Stefania Maria Rita Rizzo, Ilaria Attili, Antonio Passaro, Thomas Zilli, Francesco Martucci, Luca Bonomo, Filippo Del Grande, Monica Casiraghi, Filippo De Marinis, Lorenzo Spaggiari
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options. Current oncology (Toronto, Ont.) 30 (3) (2023)
Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, Ester Del Signore, Carla Corvaja, Chiara Corti, Edoardo Crimini, Antonio Passaro, Filippo de Marinis
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running? Current oncology (Toronto, Ont.) 30 (5) (2023)
Francesco Petrella, Stefania Maria Rita Rizzo, Ilaria Attili, Antonio Passaro, Thomas Zilli, Francesco Martucci, Luca Bonomo, Filippo Del Grande, Monica Casiraghi, Filippo De Marinis, Lorenzo Spaggiari
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options. Current oncology (Toronto, Ont.) 30 (3) (2023)
Ilaria Attili, Carla Corvaja, Gianluca Spitaleri, Ester Del Signore, Pamela Trillo Aliaga, Antonio Passaro, Filippo de Marinis
New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations. Cancers 15 (20) (2023)
Lisa Rinaldi, Elena Guerini Rocco, Gianluca Spitaleri, Sara Raimondi, Ilaria Attili, Alberto Ranghiero, Giulio Cammarata, Marta Minotti, Giuliana Lo Presti, Francesca De Piano, Federica Bellerba, Gianluigi Funicelli, Stefania Volpe, Serena Mora, Cristiana Fodor, Cristiano Rampinelli, Massimo Barberis, Filippo De Marinis, Barbara Alicja Jereczek-Fossa, Roberto Orecchia, Stefania Maria Rita Rizzo, Francesca Botta
Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma Patients. Cancers 15 (18) (2023)
Francesco Petrella, Stefania Maria Rita Rizzo, Ilaria Attili, Antonio Passaro, Thomas Zilli, Francesco Martucci, Luca Bonomo, Filippo Del Grande, Monica Casiraghi, Filippo De Marinis, Lorenzo Spaggiari
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options. Current oncology (Toronto, Ont.) 30 (3) (2023)
Cesare Gridelli, Marcello Tiseo, Diego Luigi Cortinovis, Maria Rita Migliorino, Vito Barbieri, Paolo Bironzo, Alessandra Bearz, Ilaria Attili, Filippo de Marinis
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion. Current oncology (Toronto, Ont.) 30 (11) (2023)
Ilaria Attili, Antonio Passaro, Pasquale Pisapia, Umberto Malapelle, Filippo de Marinis
Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence. Current oncology (Toronto, Ont.) 29 (1) (2022)
Antonio Passaro, Ilaria Attili, Filippo de Marinis
Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage Resectable Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Stefano Indraccolo, Elisabetta Zulato, Alberto Pavan, Ilaria Attili, Giulia Pasello, PierFranco Conte, Stefano Indraccolo
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer. International journal of molecular sciences 20 (8) (2019)
Ilaria Attili, Niki Karachaliou, Laura Bonanno, Jordi Berenguer, Jillian Bracht, Jordi Codony-Servat, Carles Codony-Servat, Masaoki Ito, Rafael Rosell
STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer. Therapeutic advances in medical oncology 10 (2018)